Papers

2

Total Citations

23

H-Index

2

About

Delphine Dean is a biomedical researcher whose work spans diagnostic technology, automation, and infectious disease response. She has made notable contributions to the development of efficient, scalable diagnostic strategies, particularly in the context of the COVID-19 pandemic. Her research on SARS-CoV-2 detection has focused on leveraging open-source pipetting robots to streamline quantitative reverse transcriptase PCR (qRT-PCR) saliva-based testing, addressing critical bottlenecks in epidemiological surveillance and clinical diagnostics during a period of unprecedented global health demand. By integrating accessible automation technologies into laboratory workflows, Dean's work has helped lower barriers to high-throughput testing, making accurate COVID-19 diagnostics more feasible across diverse research and clinical settings. Her publications in this area have collectively garnered over 20 citations, reflecting growing recognition of her practical, innovation-driven approach to solving real-world public health challenges. Dean's research exemplifies the intersection of biomedical engineering and infectious disease science, demonstrating how thoughtful application of automation can meaningfully advance diagnostic capacity during health crises — a contribution of lasting relevance to both researchers and public health practitioners.

Research Focus

Key Achievements

2
H-Index
2
Papers
23
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots
16 citations · 2022
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Sensors (United States), Clemson University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 1 days ago